HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao-Kun Li Selected Research

Spinal Cord Injuries (Spinal Cord Injury)

4/2021Exogenous platelet-derived growth factor improves neurovascular unit recovery after spinal cord injury.
10/2016Regulation of Caveolin-1 and Junction Proteins by bFGF Contributes to the Integrity of Blood-Spinal Cord Barrier and Functional Recovery.
1/2016Gelatin Nanostructured Lipid Carriers Incorporating Nerve Growth Factor Inhibit Endoplasmic Reticulum Stress-Induced Apoptosis and Improve Recovery in Spinal Cord Injury.
12/2013Regulation of autophagy and ubiquitinated protein accumulation by bFGF promotes functional recovery and neural protection in a rat model of spinal cord injury.
1/2013Exogenous basic fibroblast growth factor inhibits ER stress-induced apoptosis and improves recovery from spinal cord injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiao-Kun Li Research Topics

Disease

13Neoplasms (Cancer)
01/2022 - 05/2003
9Wounds and Injuries (Trauma)
01/2023 - 12/2004
5Thrombocytopenia (Thrombopenia)
01/2022 - 01/2016
5Spinal Cord Injuries (Spinal Cord Injury)
04/2021 - 01/2013
4Esophageal Neoplasms (Esophageal Cancer)
04/2024 - 09/2021
4Inflammation (Inflammations)
04/2024 - 06/2009
4Infections
01/2023 - 08/2017
3Ischemia
01/2020 - 12/2004
2Sarcopenia
04/2024 - 01/2024
2COVID-19
01/2023 - 01/2022
2Pneumonia (Pneumonitis)
11/2022 - 01/2020
2Alopecia (Baldness)
11/2020 - 07/2018
2Anastomotic Leak
10/2020 - 01/2020
2Hypoxia (Hypoxemia)
01/2020 - 12/2009
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2018 - 02/2015
2Leukopenia
01/2018 - 01/2016
2Lymphopenia (Lymphocytopenia)
01/2018 - 01/2016
2Reperfusion Injury
11/2017 - 12/2004
2Diabetes Complications
07/2017 - 01/2008
2Body Weight (Weight, Body)
07/2017 - 10/2008
2Brain Injuries (Brain Injury)
12/2016 - 12/2009
2Diabetic Cardiomyopathies
02/2016 - 06/2009
2Breast Neoplasms (Breast Cancer)
03/2013 - 01/2008
2Hepatocellular Carcinoma (Hepatoma)
11/2003 - 05/2003
1Fatty Liver
04/2024
1Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2024
1Disease Progression
01/2024
1Acute Lung Injury
11/2022
1Nausea
03/2022
1Vomiting
03/2022
1Esophageal Squamous Cell Carcinoma
09/2021
1Vocal Cord Paralysis
02/2021
1Deglutition Disorders (Dysphagia)
10/2020
1Pathologic Constriction (Stenosis)
10/2020
1Hemorrhage
10/2020
1Myasthenia Gravis
08/2020
1Surgical Blood Loss
06/2020
1Necrosis
01/2020
1Vascular Remodeling
01/2020
1Surgical Wound Infection
01/2020
1Ulcerative Colitis
10/2019
1Colitis
10/2019
1Anorectal Malformations
01/2019
1Glioblastoma (Glioblastoma Multiforme)
11/2018

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
07/2018 - 11/2008
6Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
11/2017 - 12/2009
4Liposomes (Liposome)IBA
10/2019 - 01/2008
4Fibroblast Growth Factor 1 (FGF-1)IBA
02/2016 - 12/2004
4Therapeutic UsesIBA
01/2013 - 12/2004
3Glucose (Dextrose)FDA LinkGeneric
01/2017 - 03/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2022 - 06/2009
2C-Reactive ProteinIBA
11/2022 - 01/2020
2Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2017
2Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
01/2019 - 01/2018
2Blood Glucose (Blood Sugar)IBA
02/2018 - 07/2017
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2018 - 01/2016
2Nerve Growth Factor (NGF)IBA
01/2017 - 01/2016
2LipidsIBA
01/2016 - 06/2009
2Epirubicin (Ellence)FDA LinkGeneric
03/2013 - 02/2011
2Phospholipids (Phosphatides)FDA LinkGeneric
02/2011 - 07/2010
1Triglycerides (Triacylglycerol)IBA
04/2024
1fibroblast growth factor 21IBA
04/2024
1Glutamic Acid (Glutamate)FDA Link
01/2023
1HydrogelsIBA
01/2023
1Glutamine (L-Glutamine)FDA Link
01/2023
1Interleukin-6 (Interleukin 6)IBA
11/2022
1LipopolysaccharidesIBA
11/2022
1N-tosyllysine methyl esterIBA
09/2021
1CollagenIBA
04/2021
1Chloroquine (Aralen)FDA LinkGeneric
04/2021
1Platelet-Derived Growth FactorIBA
04/2021
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
11/2020
1Minoxidil (Rogaine)FDA LinkGeneric
11/2020
1CytokinesIBA
10/2020
1InflammasomesIBA
01/2020
1Mitochondrial DNA (mtDNA)IBA
01/2020
1Interleukin-8 (Interleukin 8)IBA
01/2020
1Sirtuin 1IBA
01/2020
1Contractile ProteinsIBA
01/2020
1InterleukinsIBA
01/2020
1Fibroblast Growth Factor 7FDA Link
10/2019
1Fibroins (Fibroin)IBA
11/2018
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
11/2018
1Recombinant Fusion ProteinsIBA
07/2018
1Safflower OilFDA Link
07/2018
1Fibroblast Growth Factor 9IBA
07/2018

Therapy/Procedure

12Therapeutics
01/2023 - 03/2013
4Neoadjuvant Therapy
04/2024 - 01/2022
4Length of Stay
01/2022 - 01/2020
3Esophagectomy
01/2024 - 10/2020
3Microbubbles
02/2016 - 07/2010
3Drug Therapy (Chemotherapy)
03/2013 - 07/2010
2Immunomodulation
01/2023 - 02/2008
2Intraperitoneal Injections
04/2021 - 10/2008
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2023
1Chemoradiotherapy
01/2022
1Lymph Node Excision (Lymph Node Dissection)
02/2021
1Thymectomy
08/2020
1Aftercare (After-Treatment)
11/2018
1Bioreactors (Bioreactor)
07/2018